Literature DB >> 73554

Haemostatic disorders and respiratory distress in the newborn.

C Boyer, D Ménaché, F Beaufils, H Mathieu.   

Abstract

Coagulation and fibrinolysis studies were performed on 64 newborns; 16 premature infants with hyaline membrane disease (HMD), 17 newborns with other forms of respiratory distress syndrome (RDS) (8 of them were premature), 31 healthy newborns (11 of them were premature). All the babies were studied once in the first 48 hours of life. There was no significant difference between sick and healthy babies for 5 parameters; platelet count, factor VIII, fibrinogen, fibrin(ogen) degradation products, euglobulin lysis time. Factor II, VII and X were low in all infants, and premature infants had significantly lower levels compared to full term newborns. Factor V, plasminogen, alpha 2 macroglobulin (alpha 2M) and antithrombin III (AT III) levels were significantly lower in sick infants. Except for AT III, these deficiencies were not related to prematurity. No significant difference was found between HMD and other RDS. Of the 33 sick infants, 5 developed laboratory findings consistent with disseminated intravascular coagulation (DIC). The results indicate that the coagulation and fibrinolytic abnormalities reported are not specific to HMD.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73554     DOI: 10.1007/BF01641119

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  A SIMPLE METHOD FOR THE INSTANTANEOUS QUANTITATION OF FIBRINOGEN THE FPT-TEST.

Authors:  C VERMYLEN; M VERSTRAETE; R DEVREKER
Journal:  Acta Clin Belg       Date:  1963       Impact factor: 1.264

2.  Fibrinolytic activity in the serum of infants with and without the hyaline membrane syndrome.

Authors:  E A SAMARTZIS; C D COOK; A J RUDOLPH
Journal:  Acta Paediatr       Date:  1960-11       Impact factor: 2.299

3.  A deficiency of pulmonary fibrinolysis in hyaline-membrane disease.

Authors:  J LIEBERMAN; F KELLOGG
Journal:  N Engl J Med       Date:  1960-05-19       Impact factor: 91.245

4.  The nature of the hyaline membrane in asphyxia of the newborn.

Authors:  D GITLIN; J M CRAIG
Journal:  Pediatrics       Date:  1956-01       Impact factor: 7.124

5.  [New diagnostic method in hemophilia; determination of antihemophilic factors A and B].

Authors:  J P SOULIER; M J LARRIEU
Journal:  Sang       Date:  1953

6.  Studies on hyaine membrane disease.3. Thrapeutic trial of urokinase-activated huma plasmin.

Authors:  C M Ambrus; D H Weintrb; J L Ambrus
Journal:  Pediatrics       Date:  1966-08       Impact factor: 7.124

7.  Evolution of blood clotting factor leves in premature infants during the first 10 days of life: a study of 96 cases with comparison between clinical status and blood clotting factor levels.

Authors:  A H Jensen; F Josso; P Zamet; M Monset-Couchard; A Minkowski
Journal:  Pediatr Res       Date:  1973-07       Impact factor: 3.756

8.  Coagulation studies in severe birth asphyxia.

Authors:  J M Chessells; J S Wigglesworth
Journal:  Arch Dis Child       Date:  1971-06       Impact factor: 3.791

9.  Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. II. The effect of heparin.

Authors:  M Markarian; L O Lubchenco; E Rosenblüt; F Fernandez; D Lang; J J Jackson; A E Bannon; A Lindley; J H Githens; R Martorell
Journal:  Biol Neonate       Date:  1971

10.  Coagulation factors in pregnant women and premature infants with and without the respiratory distress syndrome.

Authors:  M Markarian; A Lindley; J J Jackson; A Bannon
Journal:  Thromb Diath Haemorrh       Date:  1967-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.